Indonesia certified – 11th Jan Nikkei Asia It was reported that the Indonesian Food and Drug Administration (BPOM) approved a vaccine against COVID-19 developed by Sinovak Biotech Of China to use emergency Paving the way for Indonesia to start a planned mass vaccination program. It is also the first country outside of China to open the green light for xinovac vaccines.
AP
–
Indonesia received 3 million xinovac vaccines, and 1.2 million were distributed last week to 34 provinces.
Penny Leukito BPOM chief said data during the end of human trials in Indonesia show that The vaccination was 65.3% effective, well below the 78% efficiency rate reported in a nearby trial in Brazil. And below the 91.25% efficiency rate that appeared in tests in Turkey. But exceeds the 50% efficiency rate recommended by the World Health Organization.
Bloomberg
–
The Indonesian Ministry of Health said. The country will receive another 15 million doses of the Xenovak vaccine on Tuesday, Jan. 12. President Joko Widodo Will receive the first vaccine after 1.3 million health workers
Indonesia’s health ministry has set a nationwide vaccination target of 181 million from 270 million for 12 months. So far, 229 million doses of the COVID-19 vaccine have been made from Xinovak, Novak, and the global vaccine program like Kovak; and It is negotiating to buy 50 million doses of the vaccine from AstraZeneca and Pfizer and wait for Halal approval by BPOM and the Ulama Council.
AFP
–
For the infected Indonesia has 8,692 new infections, an increase to 836,718, and the death toll of 24,343, an increase of 214.The Indonesian government extends the foreign immigration ban two weeks after the first ban was finalized on 14 m. C.
–
